The Supreme Court on Friday granted the HIV-prevention field a historic win — yet with a major caveat — as it upheld a ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

At the beginning of June, the Texas Department of State Health Services asked all programs funded by the CDC’s HIV Prevention ...

Congressional leaders celebrated the restored $20 million in previously frozen HIV prevention funds and surveillance programs ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...

The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...

A model that can estimate the need for pre-exposure prophylaxis (PrEP) in the US can help to clarify use patterns to address ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, ...

Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...